← Back to Analyst Consensus 
PRCT Hold
PROCEPT BioRobotics Corp
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Aug 5, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 5, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 5, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 5, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Jul 6, 2026 | Truist Securities | downgrade | Buy → Hold | — | 54% |
| Jun 24, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| Jun 11, 2026 | Leerink Partners | downgrade | Outperform → Market Perform | — | 51% |
| Apr 30, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Mar 6, 2026 | Baird | initiate | — → Neutral | — | 55% |
| Mar 2, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Feb 26, 2026 | Leerink Partners | maintain | Outperform → Outperform | $30 | 51% |
| Feb 26, 2026 | TD Cowen | maintain | Buy → Buy | $34 | 54% |
| Feb 26, 2026 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Feb 26, 2026 | Piper Sandler | maintain | Overweight → Overweight | $28 | 54% |
| Feb 26, 2026 | Wells Fargo | maintain | Overweight → Overweight | $34 | 54% |
| Feb 26, 2026 | B of A Securities | downgrade | Neutral → Underperform | $20 | 53% |
| Dec 18, 2025 | Truist Securities | maintain | Buy → Buy | $47 | 54% |
| Dec 12, 2025 | UBS | initiate | — → Buy | $62 | 54% |
| Dec 8, 2025 | B of A Securities | downgrade | Buy → Neutral | $38 | 53% |
| Dec 2, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $51 | 54% |
| Nov 5, 2025 | TD Cowen | maintain | Buy → Buy | $50 | 54% |
| Nov 5, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $50 | 54% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $51 | 54% |
| Oct 15, 2025 | Truist Securities | maintain | Buy → Buy | $50 | 54% |
| Sep 16, 2025 | BTIG | reiterate | Neutral → Neutral | $0 | 52% |
| Sep 2, 2025 | Oppenheimer | upgrade | Perform → Outperform | $60 | 52% |
| Aug 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $58 | 54% |
| Aug 7, 2025 | Piper Sandler | maintain | Overweight → Overweight | $55 | 54% |
| Jul 15, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $68 | 54% |
| Jul 7, 2025 | Oppenheimer | initiate | — → Perform | $0 | 52% |
| Apr 25, 2025 | B of A Securities | maintain | Buy → Buy | $84 | 53% |
| Apr 11, 2025 | Truist Securities | maintain | Buy → Buy | $70 | 54% |
| Feb 26, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $95 | 54% |
| Feb 26, 2025 | Truist Securities | reiterate | Buy → Buy | $90 | 54% |
| Dec 2, 2024 | Morgan Stanley | initiate | — → Overweight | $105 | 54% |
| Nov 14, 2024 | Jefferies | initiate | — → Hold | $95 | 52% |
| Oct 30, 2024 | Truist Securities | reiterate | Buy → Buy | $105 | 54% |
| Oct 8, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $75 | 54% |
| Sep 16, 2024 | TD Cowen | maintain | Buy → Buy | $99 | 54% |
| Sep 3, 2024 | Truist Securities | maintain | Buy → Buy | $95 | 54% |
| Aug 22, 2024 | B of A Securities | maintain | Buy → Buy | $94 | 53% |
| Aug 2, 2024 | Wells Fargo | maintain | Overweight → Overweight | $69 | 54% |
| Aug 2, 2024 | Truist Securities | reiterate | Buy → Buy | $74 | 54% |
| Jul 16, 2024 | Truist Securities | maintain | Buy → Buy | $79 | 54% |
| May 6, 2024 | TD Cowen | maintain | Buy → Buy | $75 | 54% |
| May 6, 2024 | Piper Sandler | maintain | Overweight → Overweight | $75 | 54% |
| May 2, 2024 | Truist Securities | maintain | Buy → Buy | $72 | 54% |
| Feb 28, 2024 | Truist Securities | maintain | Buy → Buy | $58 | 54% |
| Jan 9, 2024 | Wells Fargo | maintain | Overweight → Overweight | $47 | 54% |
Price Target Trend
May 17, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days